Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats

Por Al-Rasheed, Nouf M, Al-Rasheed, Nawal M, Hasan, Iman H, Al-Amin, Maha A, Al-Ajmi, Hanaa N, Mahmoud, Ayman M
Publicado no Drug Des Devel Ther (2016)

Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects

Por Al-Samhari, Marwa M, Al-Rasheed, Nouf M, Al-Rejaie, Salim, Al-Rasheed, Nawal M, Hasan, Iman H, Mahmoud, Ayman M, Dzimiri, Nduna
Publicado no Exp Biol Med (Maywood) (2015)

Protective Effects of Silymarin, Alone or in Combination with Chlorogenic Acid and/or Melatonin, Against Carbon Tetrachloride-induced Hepatotoxicity

Por Al-Rasheed, Nouf, Faddah, Laila, Al-Rasheed, Nawal, Bassiouni, Yieldez A., Hasan, Iman H., Mahmoud, Ayman M., Mohamad, Raeesa A., Yacoub, Hazar I.
Publicado no Pharmacogn Mag (2016)

Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats

Por Al-Rasheed, Nawal M., Al-Rasheed, Nouf M., Hasan, Iman H., Al-Amin, Maha A., Al-Ajmi, Hanaa N., Mohamad, Raeesa A., Mahmoud, Ayman M.
Publicado no Oxid Med Cell Longev (2017)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway

Por Al-rasheed, Nouf M, Al-Oteibi, Maha M, Al-Manee, Reem Z, Al-shareef, Sarah A, Al-Rasheed, Nawal M, Hasan, Iman H, Mohamad, Raeesa A, Mahmoud, Ayman M
Publicado no Drug Des Devel Ther (2015)